Multifunctional gold nanorod theragnostics probed by multi-photon imaging

Brittany Book Newell, Yuling Wang, Joseph Irudayaraj

Research output: Contribution to journalArticle

Abstract

This study exhibits the fabrication of target-specific Gold nanorods (GNRs) coupled with an anti-tumorigenic apoptotic drug and provides tracking of the labeled particles as they migrate through cells and release their drug-load to targeted cancer cells. We utilize the photoluminescence property of GNRs and their ability to be conjugated with multiple agents to transform facile rods to a targeted drug delivery vehicle. GNRs of aspect ratio 2.8 were conjugated with a targeting ligand, folic acid and an anthracycline drug, Doxorubicin. The multifunctional nanorods were then used to target folate receptor expressing cancers cells for the delivery of a concentration dependent dosage of Doxorubicin (DOX). By utilizing the photoluminescence of GNRs and the innate fluorescence of DOX, multi-photon fluorescence lifetime imaging was utilized to monitor the uptake of functionalized nanorods, the release of the drug and its localization in living cells. We show that these nano-vehicles successfully targeted cancer cells over expressing folate receptors and showed low toxicity to control cell lines. Release of DOX was observed in the cytoplasmic region and after 16 h was found to be redistributed in the nucleus resulting in cell death. Our theragnostic approach demonstrates the fabrication of multifunctional GNRs for targeted drug delivery and monitoring of the drug and the vehicle by multi-photon microscopy using fluorescence intensity and lifetime imaging.

Original languageEnglish (US)
Pages (from-to)330-337
Number of pages8
JournalEuropean Journal of Medicinal Chemistry
Volume48
DOIs
StatePublished - Feb 1 2012
Externally publishedYes

Fingerprint

Nanotubes
Nanorods
Photons
Gold
Imaging techniques
Doxorubicin
Cells
Folic Acid
Pharmaceutical Preparations
Photoluminescence
Fluorescence
Fabrication
Neoplasms
Drug Monitoring
Fluorescence microscopy
Anthracyclines
Optical Imaging
Cell death
Fluorescence Microscopy
Toxicity

Keywords

  • Doxorubicin
  • Folic acid
  • Gold nanorods
  • Multi-photon imaging
  • Targeted drug delivery
  • Theragnostics

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Cite this

Multifunctional gold nanorod theragnostics probed by multi-photon imaging. / Book Newell, Brittany; Wang, Yuling; Irudayaraj, Joseph.

In: European Journal of Medicinal Chemistry, Vol. 48, 01.02.2012, p. 330-337.

Research output: Contribution to journalArticle

@article{40b44eedbbb84007a8a196e74713f002,
title = "Multifunctional gold nanorod theragnostics probed by multi-photon imaging",
abstract = "This study exhibits the fabrication of target-specific Gold nanorods (GNRs) coupled with an anti-tumorigenic apoptotic drug and provides tracking of the labeled particles as they migrate through cells and release their drug-load to targeted cancer cells. We utilize the photoluminescence property of GNRs and their ability to be conjugated with multiple agents to transform facile rods to a targeted drug delivery vehicle. GNRs of aspect ratio 2.8 were conjugated with a targeting ligand, folic acid and an anthracycline drug, Doxorubicin. The multifunctional nanorods were then used to target folate receptor expressing cancers cells for the delivery of a concentration dependent dosage of Doxorubicin (DOX). By utilizing the photoluminescence of GNRs and the innate fluorescence of DOX, multi-photon fluorescence lifetime imaging was utilized to monitor the uptake of functionalized nanorods, the release of the drug and its localization in living cells. We show that these nano-vehicles successfully targeted cancer cells over expressing folate receptors and showed low toxicity to control cell lines. Release of DOX was observed in the cytoplasmic region and after 16 h was found to be redistributed in the nucleus resulting in cell death. Our theragnostic approach demonstrates the fabrication of multifunctional GNRs for targeted drug delivery and monitoring of the drug and the vehicle by multi-photon microscopy using fluorescence intensity and lifetime imaging.",
keywords = "Doxorubicin, Folic acid, Gold nanorods, Multi-photon imaging, Targeted drug delivery, Theragnostics",
author = "{Book Newell}, Brittany and Yuling Wang and Joseph Irudayaraj",
year = "2012",
month = "2",
day = "1",
doi = "10.1016/j.ejmech.2011.12.036",
language = "English (US)",
volume = "48",
pages = "330--337",
journal = "European Journal of Medicinal Chemistry",
issn = "0223-5234",
publisher = "Elsevier Masson SAS",

}

TY - JOUR

T1 - Multifunctional gold nanorod theragnostics probed by multi-photon imaging

AU - Book Newell, Brittany

AU - Wang, Yuling

AU - Irudayaraj, Joseph

PY - 2012/2/1

Y1 - 2012/2/1

N2 - This study exhibits the fabrication of target-specific Gold nanorods (GNRs) coupled with an anti-tumorigenic apoptotic drug and provides tracking of the labeled particles as they migrate through cells and release their drug-load to targeted cancer cells. We utilize the photoluminescence property of GNRs and their ability to be conjugated with multiple agents to transform facile rods to a targeted drug delivery vehicle. GNRs of aspect ratio 2.8 were conjugated with a targeting ligand, folic acid and an anthracycline drug, Doxorubicin. The multifunctional nanorods were then used to target folate receptor expressing cancers cells for the delivery of a concentration dependent dosage of Doxorubicin (DOX). By utilizing the photoluminescence of GNRs and the innate fluorescence of DOX, multi-photon fluorescence lifetime imaging was utilized to monitor the uptake of functionalized nanorods, the release of the drug and its localization in living cells. We show that these nano-vehicles successfully targeted cancer cells over expressing folate receptors and showed low toxicity to control cell lines. Release of DOX was observed in the cytoplasmic region and after 16 h was found to be redistributed in the nucleus resulting in cell death. Our theragnostic approach demonstrates the fabrication of multifunctional GNRs for targeted drug delivery and monitoring of the drug and the vehicle by multi-photon microscopy using fluorescence intensity and lifetime imaging.

AB - This study exhibits the fabrication of target-specific Gold nanorods (GNRs) coupled with an anti-tumorigenic apoptotic drug and provides tracking of the labeled particles as they migrate through cells and release their drug-load to targeted cancer cells. We utilize the photoluminescence property of GNRs and their ability to be conjugated with multiple agents to transform facile rods to a targeted drug delivery vehicle. GNRs of aspect ratio 2.8 were conjugated with a targeting ligand, folic acid and an anthracycline drug, Doxorubicin. The multifunctional nanorods were then used to target folate receptor expressing cancers cells for the delivery of a concentration dependent dosage of Doxorubicin (DOX). By utilizing the photoluminescence of GNRs and the innate fluorescence of DOX, multi-photon fluorescence lifetime imaging was utilized to monitor the uptake of functionalized nanorods, the release of the drug and its localization in living cells. We show that these nano-vehicles successfully targeted cancer cells over expressing folate receptors and showed low toxicity to control cell lines. Release of DOX was observed in the cytoplasmic region and after 16 h was found to be redistributed in the nucleus resulting in cell death. Our theragnostic approach demonstrates the fabrication of multifunctional GNRs for targeted drug delivery and monitoring of the drug and the vehicle by multi-photon microscopy using fluorescence intensity and lifetime imaging.

KW - Doxorubicin

KW - Folic acid

KW - Gold nanorods

KW - Multi-photon imaging

KW - Targeted drug delivery

KW - Theragnostics

UR - http://www.scopus.com/inward/record.url?scp=84862915258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862915258&partnerID=8YFLogxK

U2 - 10.1016/j.ejmech.2011.12.036

DO - 10.1016/j.ejmech.2011.12.036

M3 - Article

C2 - 22230223

AN - SCOPUS:84862915258

VL - 48

SP - 330

EP - 337

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

SN - 0223-5234

ER -